Showing results (81-90 of 142) with videos related to
Sort By:
Pageof 15
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2021
Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patientsAli Afshar-Oromieh, Marcelo Livorsi da Cunha, Jairo Wagner, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 26, 2015
(68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patientsFlorian Sterzing, Clemens Kratochwil, Hannah Fiedler, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2016
Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timingAli Afshar-Oromieh, Henrik Hetzheim, Wolfgang Kübler, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021
In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapyGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.Nuclear Medicine Communications|January 22, 2021
The influence of colour scale in lesion detection and patient-based sensitivity in [68Ga]Ga-PSMA-PET/CTClemens Mingels, Christos Sachpekidis, Karl P Bohn, et al.Molecular Imaging and Biology|February 15, 2014
Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CTSarah Wulfert, Clemens Kratochwil, Peter L Choyke, et al.Cancers|July 24, 2021
Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate CancerGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2023
[177Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney DiseaseLorenzo Mercolli, Clemens Mingels, Giulia Manzini, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2019
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and gangliaIan Alberts, Christos Sachpekidis, Lotte Dijkstra, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017
PSMA Ligands for PET Imaging of Prostate CancerSarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.Pageof 15